Beyond Air Announces Executive & Director Changes

Ticker: XAIR · Form: 8-K · Filed: Mar 14, 2025 · CIK: 1641631

Beyond Air, Inc. 8-K Filing Summary
FieldDetail
CompanyBeyond Air, Inc. (XAIR)
Form Type8-K
Filed DateMar 14, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: management-change, compensation, filing

TL;DR

Beyond Air shakes up leadership, files new exec comp details.

AI Summary

Beyond Air, Inc. announced on March 11, 2025, changes in its board and executive team, including the departure of a director and the appointment of a new officer. The company also disclosed compensatory arrangements for certain officers and other events, with financial statements and exhibits filed as part of the report.

Why It Matters

Changes in leadership and executive compensation can signal shifts in company strategy or financial health, impacting investor confidence.

Risk Assessment

Risk Level: medium — Executive and director changes, along with compensatory arrangements, can introduce uncertainty regarding future strategy and operations.

Key Players & Entities

  • Beyond Air, Inc. (company) — Registrant
  • AIT Therapeutics, Inc. (company) — Former Company Name
  • KokiCare, Inc. (company) — Former Company Name

FAQ

What specific roles were affected by the executive and director changes?

The filing indicates the departure of a director and the appointment of a new officer, along with details on compensatory arrangements for certain officers, but does not specify the exact roles in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on March 11, 2025.

What is Beyond Air, Inc.'s state of incorporation?

Beyond Air, Inc. is incorporated in Delaware.

What is the business address of Beyond Air, Inc.?

The business address of Beyond Air, Inc. is 900 Stewart Avenue, Suite 301, Garden City, NY 11530.

What other former company names has Beyond Air, Inc. used?

Beyond Air, Inc. has previously operated under the names AIT Therapeutics, Inc. (name change effective January 17, 2017) and KokiCare, Inc. (name change effective May 7, 2015).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 14, 2025 regarding Beyond Air, Inc. (XAIR).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.